FibroBiologics CEO to Present at BFC Global Healthcare Business Development and Investment Conference
I'm PortAI, I can summarize articles.
FibroBiologics Inc., a clinical-stage biotechnology company, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference on January 11, 2026, at 4:30 p.m. PT in San Francisco. The company focuses on developing therapeutics for chronic diseases using fibroblast technology. This news was generated by Public Technologies and is for informational purposes only, not financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments